EZH2 accompanies prostate cancer progression
Crossref DOI link: https://doi.org/10.1038/s41556-021-00744-4
Published Online: 2021-09-06
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xin, Li http://orcid.org/0000-0002-7138-0042
Text and Data Mining valid from 2021-09-01
Version of Record valid from 2021-09-01
Article History
First Online: 6 September 2021
Competing interests
: The authors declare no competing interests.